BMS's split from Mead Johnson boosts Q4 income by $7 million
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibb's split-off of its nutritionals business Mead Johnson boosted its fourth-quarter earnings by nearly seven-fold to $8 billion.